PH13837A - Influenza vaccine containing purified neuraminidase antigen and method of using the same - Google Patents
Influenza vaccine containing purified neuraminidase antigen and method of using the sameInfo
- Publication number
- PH13837A PH13837A PH17976A PH17976A PH13837A PH 13837 A PH13837 A PH 13837A PH 17976 A PH17976 A PH 17976A PH 17976 A PH17976 A PH 17976A PH 13837 A PH13837 A PH 13837A
- Authority
- PH
- Philippines
- Prior art keywords
- same
- influenza vaccine
- vaccine containing
- containing purified
- neuraminidase antigen
- Prior art date
Links
- 102000005348 Neuraminidase Human genes 0.000 title 1
- 108010006232 Neuraminidase Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229960003971 influenza vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/541,512 US4029763A (en) | 1974-08-05 | 1975-01-16 | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH13837A true PH13837A (en) | 1980-10-16 |
Family
ID=24159889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH17976A PH13837A (en) | 1975-01-16 | 1976-01-15 | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU507149B2 (en) |
| BE (1) | BE837603A (en) |
| CA (1) | CA1073355A (en) |
| FR (1) | FR2297635A1 (en) |
| GB (1) | GB1536475A (en) |
| NL (1) | NL7600443A (en) |
| PH (1) | PH13837A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2483779A1 (en) * | 1980-06-05 | 1981-12-11 | Synthelabo | PROCESS FOR ISOLATING VIRAL GLYCOPROTETIC ANTIGENS AND APPLICATION THEREOF TO VACCINE PREPARATION |
-
1976
- 1976-01-09 AU AU10163/76A patent/AU507149B2/en not_active Expired
- 1976-01-15 BE BE163545A patent/BE837603A/en not_active IP Right Cessation
- 1976-01-15 PH PH17976A patent/PH13837A/en unknown
- 1976-01-15 FR FR7600974A patent/FR2297635A1/en active Granted
- 1976-01-15 CA CA243,608A patent/CA1073355A/en not_active Expired
- 1976-01-16 GB GB1722/76A patent/GB1536475A/en not_active Expired
- 1976-01-16 NL NL7600443A patent/NL7600443A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BE837603A (en) | 1976-05-03 |
| FR2297635A1 (en) | 1976-08-13 |
| AU1016376A (en) | 1977-07-14 |
| AU507149B2 (en) | 1980-02-07 |
| CA1073355A (en) | 1980-03-11 |
| FR2297635B1 (en) | 1980-06-27 |
| GB1536475A (en) | 1978-12-20 |
| NL7600443A (en) | 1976-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1075017B (en) | PROCEDURE FOR THE TREATMENT OF ANTOCYANIN EXTRACTS | |
| JPS52114018A (en) | Purification and isolation of hepatisis virus for producing vaccine | |
| IT1069277B (en) | PROCESS AND PLANT FOR THE PURIFICATION OF HALOGENOSILANS | |
| AU504454B2 (en) | Hepatitis b antigen and vaccine | |
| AU509878B2 (en) | Preparation of tertiary aliphatic amines | |
| IT1063377B (en) | PROCEDURE FOR THE PREPARATION OF HYDROFORMILATION PRODUCTS | |
| IT1062549B (en) | PROCESS FOR THE PREPARATION OF UNSATURATED NITRILS | |
| IL51864A0 (en) | Rabies vaccine and its preparation | |
| FR2298529A1 (en) | CYCLOALIPHATIC AMINES | |
| ZA764124B (en) | Novel rabies virus vaccine and processes | |
| JPS51133414A (en) | Production of vaccine against viral hepatisis | |
| JPS5244230A (en) | Detection of hepatisis antigen and antibody and hepatisis vaccine | |
| ZA761346B (en) | Vaccine for active immunization containing hepatitis b surface antigen and associated antigen | |
| JPS5239683A (en) | Nnaryllnn*44piperidinyl*aryll acetoamide preparation method and medicinal uses | |
| CS191254B2 (en) | Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza | |
| AU507682B2 (en) | Preparation of tertiary amines | |
| PH13837A (en) | Influenza vaccine containing purified neuraminidase antigen and method of using the same | |
| JPS5231825A (en) | Identification of virus | |
| IT1066183B (en) | PROCEDURE FOR THE PREPARATION OF GAS BLACK | |
| GR61598B (en) | Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines | |
| JPS51142528A (en) | Production of vaccine based on antigenic libosome fractionation | |
| RO77284A (en) | PROCESS FOR THE PREPARATION AND PURIFICATION OF EPOXY BREASTES | |
| ZA75992B (en) | New amine derivatives of azidophenols and the preparation thereof | |
| IT1077015B (en) | PROCESS FOR THE PREPARATION OF BUTENDIOLDIACETATES | |
| IT1069004B (en) | PROCESS FOR THE PREPARATION OF DIALOGENOVINYLCYCLOPROPANCARBOSSILATES |